MX2024008372A - Compuestos organicos deuterados y usos de los mismos - Google Patents
Compuestos organicos deuterados y usos de los mismosInfo
- Publication number
- MX2024008372A MX2024008372A MX2024008372A MX2024008372A MX2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A
- Authority
- MX
- Mexico
- Prior art keywords
- organic compounds
- deuterated organic
- compounds
- formula
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296134P | 2022-01-03 | 2022-01-03 | |
| US202263345007P | 2022-05-23 | 2022-05-23 | |
| US202263384992P | 2022-11-25 | 2022-11-25 | |
| PCT/US2023/010050 WO2023130117A1 (en) | 2022-01-03 | 2023-01-03 | Deuterated organic compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024008372A true MX2024008372A (es) | 2024-12-06 |
Family
ID=87000368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024008372A MX2024008372A (es) | 2022-01-03 | 2024-07-02 | Compuestos organicos deuterados y usos de los mismos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250091990A1 (https=) |
| EP (1) | EP4460490A4 (https=) |
| JP (1) | JP2025501410A (https=) |
| KR (1) | KR20240132476A (https=) |
| AU (1) | AU2023204432A1 (https=) |
| CA (1) | CA3242751A1 (https=) |
| IL (1) | IL314019A (https=) |
| MX (1) | MX2024008372A (https=) |
| TW (1) | TW202340145A (https=) |
| WO (1) | WO2023130117A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202333671A (zh) | 2022-01-03 | 2023-09-01 | 美商恩格瑞爾療法公司 | 氘化有機化合物及其用途 |
| TW202517609A (zh) | 2023-07-02 | 2025-05-01 | 美商英格瑞治療公司 | 氘化有機化合物及其用途(二) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102373288B1 (ko) * | 2013-12-03 | 2022-03-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| CN104744333A (zh) * | 2013-12-26 | 2015-07-01 | 张云 | 一种奈莫必利的生产方法 |
-
2023
- 2023-01-03 TW TW112100104A patent/TW202340145A/zh unknown
- 2023-01-03 CA CA3242751A patent/CA3242751A1/en active Pending
- 2023-01-03 IL IL314019A patent/IL314019A/en unknown
- 2023-01-03 JP JP2024561730A patent/JP2025501410A/ja active Pending
- 2023-01-03 WO PCT/US2023/010050 patent/WO2023130117A1/en not_active Ceased
- 2023-01-03 EP EP23735187.9A patent/EP4460490A4/en active Pending
- 2023-01-03 KR KR1020247025927A patent/KR20240132476A/ko active Pending
- 2023-01-03 AU AU2023204432A patent/AU2023204432A1/en active Pending
- 2023-01-03 US US18/726,550 patent/US20250091990A1/en active Pending
-
2024
- 2024-07-02 MX MX2024008372A patent/MX2024008372A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023130117A1 (en) | 2023-07-06 |
| TW202340145A (zh) | 2023-10-16 |
| US20250091990A1 (en) | 2025-03-20 |
| EP4460490A1 (en) | 2024-11-13 |
| JP2025501410A (ja) | 2025-01-17 |
| AU2023204432A1 (en) | 2024-07-18 |
| EP4460490A4 (en) | 2026-03-18 |
| CA3242751A1 (en) | 2023-07-06 |
| IL314019A (en) | 2024-08-01 |
| KR20240132476A (ko) | 2024-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI202000078A (es) | Compuestos heteroaril tetracíclicos | |
| DOP2025000288A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio | |
| UY38602A (es) | Compuestos tricíclicos condensados | |
| MX2024008372A (es) | Compuestos organicos deuterados y usos de los mismos | |
| ECSP078052A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| ECSP078051A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| CL2014003181A1 (es) | Compuestos derivados de benzamidas n- sustituidas o piridinamidas n-sustituidas; composicion farmaceutica que los comprende; metodo de tratamiento; y su uso para el tratamiento de enfermedades o trastornos seleccionados de dolor, depresion y enfermedades cardiovasculares, respiratorias o psiquiatricas o combinaciones de estas. | |
| UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
| CO2022004723A2 (es) | Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1 | |
| UY28695A1 (es) | Derivados de difenilazetidona | |
| UY28691A1 (es) | Derivados de difenilazetidona | |
| UY27882A1 (es) | Compuestos quimicos | |
| SV2018005750A (es) | Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue | |
| CL2008002768A1 (es) | Compuestos derivados de carboxiciclopropil-(bis-fenil-oxamidas); composicion farmaceutica que los contiene; procedimiento para la elaboracion de las composiciones y el uso de los compuestos en el tratamiento de diabetes y trastornos del sncentre otras enfermedades. | |
| AR125457A2 (es) | Compuestos inhibidores dobles de magl y faah y composición farmacéutica | |
| MX392270B (es) | Oxisteroles sustituidos en c7 y metodos de uso de los mismos. | |
| ECSP088099A (es) | Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas | |
| UY37378A (es) | Compuestos tricíclicos fusionados de piridazinona útiles para tratar infecciones de orthomyxovirus | |
| UY40235A (es) | Compuestos de heteroarilo para el tratamiento del dolor | |
| MX2021003945A (es) | Compuestos de indolinona para uso como inhibidores de map4k1. | |
| MX394108B (es) | Derivados de indol n-sustituidos. | |
| AR054786A1 (es) | (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1 | |
| MX2024008371A (es) | Compuestos organicos deuterados y usos de los mismos | |
| EA202091400A1 (ru) | Производные пиррола в качестве ингибиторов асс | |
| CL2019001991A1 (es) | Moduladores del receptor de estrógeno. |